Tech Company Financing Transactions

TargAnox Funding Round

TargAnox closed a $5.1 million Series A funding round on 3/30/2009. Backers included Ascent Biomedical Ventures, Partners HealthCare System and Partners Innovation Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

37 Spinelli Pl.
Cambridge, MA 02138
USA

Phone

617-245-4600

Website

www.targanox.com

Email Address

[email protected]

Overview

TargAnox is focused on developing drugs to curb a sometimes disease-related biochemical condition called oxidative stress.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Geoffrey Smith

        

Chief Executive Officer

Avi Kometz

        

Chief Scientific Officer

Andrew Snyder

        

VP - R & D

Ross Stein

        

Browse more venture capital transactions:

Prev: 3/30/2009: Picard venture capital transaction
Next: 3/30/2009: BioVex venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary